Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Genscript Biotech (1548 HK)
Watchlist
Contact IR
81
Analysis
Health Care
•
Hong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Legend Biotech Corp
•
18 May 2020 07:32
Legend Biotech IPO Initiation: Choosing Therapies À La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
Arun George
Follow
286 Views
Share
bullish
•
BBI Life Sciences
•
20 Apr 2020 04:47
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...
David Blennerhassett
Follow
423 Views
Share
bullish
•
BBI Life Sciences
•
22 Jan 2020 04:39
BBI Life: Privatisation Offer For DNA Synthesizer
Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...
David Blennerhassett
Follow
661 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Jun 2018 07:55
Trade Risks Start to Impact, as China Biotech Ambitions Grow…
Cyclical indicators are softening this month - new orders index for the Philly Fed fell nearly 23 points while Japan’s PMI new export orders...
Sean Maher
214 Views
Share
bullish
•
Wuxi Biologics
•
19 Jun 2018 11:46
Wuxi Biologics Placement - Probably Not a Surprise to Sell Again when Lock-Up Expires
Biologics Holdings is looking to sell 50m shares of WuXi Biologics (Cayman) Inc. (2269 HK) worth about US$500m. Post sale, Biologics Holdings will...
Zhen Zhou, Toh
495 Views
Share
First
Previous
11
12
13
14
15
16
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.3
x